维里西瓜特在慢性心力衰竭患者中的演变作用
Ross M Dies1, Corrie N Jackson1, Chelsi J Flanagan2
1College of Medicine, Louisiana State University Health Sciences Center, Shreveport, USA.
Cureus
|January 1, 2024
概括
一种新的心力衰竭 (HF) 药物Vericiguat可以减少心脏衰竭 (HFrEF) 患者的住院和心血管死亡. 这种可溶性酸环酶刺激剂为管理这种慢性疾病提供了新的治疗选择.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心力衰竭 (HF) 是一种具有显著发病率和死亡率的渐进性疾病.
- 现有的高风湿治疗方法,包括指南导向医学疗法 (GDMT),具有局限性,需要新的治疗策略.
- 韦里西瓜特是一种可溶性瓜尼酸环酶刺激剂,向循环瓜诺辛单酸盐 (cGMP) 途径以改善心脏功能.
研究的目的:
- 评估在患有症状性慢性心力衰竭与减少射出小部分 (HFrEF) 的患者中 vericiguat 的疗效和安全性.
- 评估 vericiguat作为一种附加疗法对减少心血管死亡和HF住院治疗的影响.
主要方法:
- 维多利亚试验是一项大型临床研究,研究了症状慢性HFrEF.患者的 vericiguat.
- 患者除了接受标准的HF治疗外,还接受了 vericiguat.
- 结局包括心血管死亡或HF住院治疗的复合结果.
主要成果:
- 韦里西瓜特,当添加到标准治疗时,显著降低了症状慢性HFrEF患者的HF住院和心血管死亡的风险.
- 该研究表明,在这个患者群体中, vericiguat 的有效性和安全性概况令人期待.
结论:
- 维里西瓜特代表了治疗症状慢性HFrEF的新疗法,有可能改善临床结果.
- 它通过cGMP通路的独特作用机制为解决HF病理生理学的新方法提供了新的方法.
- 需要进一步的研究来确定长期益处和在临床实践中最佳使用.
关键词:
循环诺辛单酸盐的使用准则指导的医疗疗疗法是指导性的.心脏衰竭是因为心脏衰竭.在 hfref 中使用 hfref.住院治疗 住院治疗死亡率 死亡率传递器的质量是什么维多利亚维多利亚维多利亚维多利亚更多相关视频
相关概念视频
01:22Heart Failure Drugs: Diuretics
388
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
388
01:26Heart Failure Drugs: Inotropic Agents
591
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
591
01:22Heart Failure Drugs: β-Blockers
341
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
433
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
433
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
569
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
569